[HTML][HTML] Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases
S Mukherjee, B Shelar, S Krishna - American Journal of …, 2022 - ncbi.nlm.nih.gov
MiRNAs (miRs) have been proven to be well-validated therapeutic targets. Emerging
evidence has demonstrated that intricate, intrinsic and paradoxical functions of miRs are …
evidence has demonstrated that intricate, intrinsic and paradoxical functions of miRs are …
microRNA expression in acute myeloid leukaemia: New targets for therapy?
D Fletcher, E Brown, J Javadala, P Uysal‐Onganer… - …, 2022 - Wiley Online Library
Recent studies have shown that short non‐coding RNAs, known as microRNAs (miRNAs)
and their dysregulation, are implicated in the pathogenesis of acute myeloid leukaemia …
and their dysregulation, are implicated in the pathogenesis of acute myeloid leukaemia …
Expression, regulation and function of microRNA as important players in the transition of MDS to secondary AML and their cross talk to RNA-binding proteins
M Bauer, C Vaxevanis, N Heimer, HK Al-Ali… - International Journal of …, 2020 - mdpi.com
Myelodysplastic syndromes (MDS), heterogeneous diseases of hematopoietic stem cells,
exhibit a significant risk of progression to secondary acute myeloid leukemia (sAML) that are …
exhibit a significant risk of progression to secondary acute myeloid leukemia (sAML) that are …
Clinical applications of MicroRNAs in acute myeloid leukemia: a mini-review
B Bhatnagar, R Garzon - Frontiers in Oncology, 2021 - frontiersin.org
MicroRNAs (miRs) are short non-coding RNAs, typically 18-25 nucleotides in length, that are
critically important, through their direct effects on target mRNAs, in a variety of cellular …
critically important, through their direct effects on target mRNAs, in a variety of cellular …
Targeting microRNA in hematologic malignancies
Z Han, ST Rosen, C Querfeld - Current opinion in oncology, 2020 - journals.lww.com
Targeting microRNA in hematologic malignancies : Current Opinion in Oncology Targeting
microRNA in hematologic malignancies : Current Opinion in Oncology Log in or Register …
microRNA in hematologic malignancies : Current Opinion in Oncology Log in or Register …
Rational biomarker development for the early and minimally invasive monitoring of AML
S Abdelhamed, JT Butler, S Jung, DW Chen… - Blood …, 2021 - ashpublications.org
Recurrent disease remains the principal cause for treatment failure in acute myeloid
leukemia (AML) across age groups. Reliable biomarkers of AML relapse risk and disease …
leukemia (AML) across age groups. Reliable biomarkers of AML relapse risk and disease …
The Effect of Blood Clots on the Quality of RNA Extracted from PAXgene Blood RNA Tubes
R Tang, L Zhu, P Zhu, R Yin, C Zheng - Biopreservation and …, 2024 - liebertpub.com
Background: PAXgene® Blood RNA tubes are routinely used in clinical research and
molecular biology applications to preserve the stability of RNA in whole blood. However, in …
molecular biology applications to preserve the stability of RNA in whole blood. However, in …
A panel of blood-derived miRNAs with a stable expression pattern as a potential pan-cancer detection signature
Introduction: MicroRNAs have a significant role in the regulation of the transcriptome.
Several miRNAs have been proposed as potential biomarkers in different malignancies …
Several miRNAs have been proposed as potential biomarkers in different malignancies …
Investigation of the expression of P-element-induced wimpy testis-interacting RNAs in human acute myeloid leukemia
P-element induced wimpy testis (PIWI)-interacting RNAs (piRNAs) are a newly known class
of small non-coding RNAs with 24–31 nucleotides in length. There are more than 20,000 …
of small non-coding RNAs with 24–31 nucleotides in length. There are more than 20,000 …
[HTML][HTML] Assessment of the diagnostic potential of miR-29a-3p and miR-92a-3p as circulatory biomarkers in acute myeloid leukemia
MM Gado, NO Mousa, MA Badawy… - Asian Pacific journal …, 2019 - ncbi.nlm.nih.gov
Background: Acute myeloid leukemia (AML) is a set of Myeloproliferative neoplasms that are
identified by excessive growth of myeloid blasts and production of abnormal blood cells …
identified by excessive growth of myeloid blasts and production of abnormal blood cells …